Stroke Warning Added to Lemtrada Boxed Label

Lemtrada Stroke Lawsuit News

The FDA is requiring Sanofi to reliable bottles of Lemtrada to reflect the side effect of potentially causing a stroke

Thursday, March 28, 2019 - The US FDA has issued a warning that should cause shock and concern among individuals suffering from Multiple Sclerosis (MS). MS patients that have been prescribed the drug Lemtrada (alemtuzumab) have reported suffering a stroke and tears in the lining of the arteries leading to their heart and brain shortly after taking the drug. Lemtrada is the marketing name for Alemtuzumab, a drug used to treat chronic multiple sclerosis as well as certain cancers using the brand names Campath, MabCampath and Campath-1H, The FDA warns that the side effects of the drug could include loss of mental capacity, physical paralysis or death. The warning was issued to the public on November 29, 2018, and includes requiring the drug's manufacturer to upgrade the warning label to "boxed" the FDA most serious warning and to include the term "stroke" to the list of potential side effects. The main benefit to MS sufferers in taking Lemtrada is that the drug helps to slow down the disease's relapse rate and treat the symptoms of the disease which are described by the Mayo Clinic as "slurred speech, fatigue, dizziness, tingling or pain in parts of your body, and problems with sexual, bowel and bladder function." Lemtrada stroke attorneys are offering a no obligation, free consultation to families and individuals suffering from Lemtrada medication side effects.

If you are an MS sufferer and taking Lemtrada you are warned to immediately be alert to the early warning signals that you could be affected which include, according to the FDA, "Sudden numbness or weakness in the face, arms, or legs, especially if it occurs on only one side of the body, sudden confusion, trouble speaking, or difficulty understanding speech, sudden trouble seeing in one or both eyes, sudden trouble with walking, dizziness, or loss of balance or coordination, sudden severe headache or neck pain." These symptoms usually occur within 24/hrs of taking the drug.

Doctors working with patients taking Lemtrada are advised to be particularly diligent. The FDA warning extends to physicians that prescribe the drug telling them to carefully monitor each Lemtrada patient for signs of headaches and to advise each patient "at every Lemtrada infusion to seek immediate emergency medical attention if they experience symptoms of ischemic or hemorrhagic stroke or cervicocephalic arterial dissection. The diagnosis is often complicated because early symptoms such as headache and neck pain are not specific. Promptly evaluate patients who complain of symptoms consistent with these conditions."

Sanofi, the maker of Lemtrada, warns potential users of the drug that it should be used only when two or more other MS drugs have failed to alleviate the relapse rate of MS seizures. Lemtrada is taken in 8 doses over a period of two years. Sanofi warns that taking Lemtrada can cause serious autoimmune issues causing the body's immune system to attack itself and that taking the drug could cause sudden death. MS patients that have had their health further damaged by suffering a Lemtrada stroke are urged to consult a Lemtrada MS stroke attorney to see if they qualify for real monetary compensation for their medical expenses, lost wages, and pain and suffering.

More Recent Lemtrada Stroke Lawsuit News:

No-Cost, No-Obligation Lemtrada Lawsuit Case Review If You or a Loved One Suffered from Lemtrada Stroke Complications

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.